Bone Densitometer Market Report 2026

Bone Densitometer Market Overview

• Bone Densitometer market size has reached to $1.45 billion in 2025 • Expected to grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Demographic Shifts Fueling Growth Aging Population's Impact On The Bone Densitometer Market • Market Trend: Technological Advancements Transforming The Bone Densitometer Market A Spotlight On Next-Generation Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bone Densitometer Market?

A bone densitometer refers to medical equipment used to calculate bone mineral density. A bone densitometer is an improved X-ray medical device used to measure the minerals and density of bones in hospitals and diagnostic centers. The bone densitometer aims to gather medical status related to loss of bone minerals, osteopenia or osteoporosis, risk of fracture, and bone-related medical conditions. The main types of bone densitometers include DXA systems, peripheral bone densitometers, radiographic absorptiometry scanners, and quantitative ultrasound scanners. The DXA (dual-energy x-ray absorptiometry) systems refer to an advanced form of x-ray technology-based bone densitometer used to measure bone mineral density. It utilizes a small dose of ionizing radiation to produce a picture of the inside of the body to measure bone loss. They are used in hospitals, clinics, diagnosis and image centers, and other end-users for cystic fibrosis diagnosis, osteoporosis & osteopenia diagnosis, rheumatoid arthritis diagnosis, and body composition measurement.

What Is The Bone Densitometer Market Growth Forecast?

The bone densitometer market size is expected to see rapid growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing investments in preventive healthcare, rising adoption of AI-enabled diagnostic imaging, expansion of outpatient diagnostic services, growing demand for portable diagnostic equipment, technological advancements in bone density measurement. Major trends in the forecast period include increasing adoption of advanced dxa systems, rising demand for early osteoporosis screening, growing integration of ai-based bone density analysis, expansion of portable bone densitometry devices, enhanced focus on preventive bone health.

Global Bone Densitometer Market Segmentation

1) By Type: DXA Systems, Peripheral Bone Densitometers, Radiographic Absorptiometry Scanners, Quantitative Ultrasound Scanners 2) By Application: Osteoporosis & Osteopenia Diagnosis, Cystic Fibrosis Diagnosis, Body Composition Measurement, Rheumatoid Arthritis Diagnosis 3) By End-User: Hospitals, Clinics, Diagnostic and Imaging Centers, Other End-Users Subsegments: 1) By DXA Systems: Central DXA Systems, Dual-Energy X-ray Absorptiometry Systems 2) By Peripheral Bone Densitometers: Peripheral Dual-Energy X-ray Absorptiometry (pDXA), Peripheral Quantitative Computed Tomography (pQCT) 3) By Radiographic Absorptiometry Scanners: Single X-ray Absorptiometry, Multi-energy Radiographic Absorptiometry 4) By Quantitative Ultrasound Scanners: Heel Ultrasound Systems, Peripheral Ultrasound Systems

What Is The Driver Of The Bone Densitometer Market?

The rising aging population is expected to propel the growth of the bone densitometer market in the coming years. The term 'aging population' refers to the increasing percentage and proportion of elderly people in the population. The world's economy, healthcare systems, and social support networks are all affected by the aging population. Older people are more likely to develop osteoporosis, which necessitates early identification and prevention, the importance of bone health, and its influence on healthcare. Bone densitometry is an essential technique for the diagnosis and therapy of osteoporosis in older people, and it has the potential to lower healthcare expenditures while improving patient outcomes. For instance, in January 2024, according to a published Pew Research Center report, a U.S.-based nonpartisan think tank specializing in public opinion polling and demographics, the U.S. aging population is expected to surge from 101,000 in 2024 to 422,000 by 2054, marking a fourfold increase. Therefore, the rising aging population is driving the bone densitometer industry.

Key Players In The Global Bone Densitometer Market

Major companies operating in the bone densitometer market are Diagnostic Medical Systems SA, GE Healthcare Technologies Inc., Hologic Inc., BeamMed Ltd., Demetech AB, Osteometer Meditech Inc., OSTEOSYS Corp., Trivitron Healthcare Private Limited, Swissray International Inc., MEDILINK Global Ltd., Xingaoyi Medical Equipment Co. Ltd., Echolight S.p.a, Eurotec Medical Systems srl, Scanflex Healthcare AB, Medonica Co. Ltd., Oscare Medical Oy, L'Acn Srl., Shenzhen Xray Electric Co. Ltd., YOZMA BMTech Co. Ltd., Nanoomtech Co. Ltd., Siemens AG, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd.

Global Bone Densitometer Market Trends and Insights

Major companies operating in the bone densitometer market are focused on providing technologically advanced solutions to meet end-customer demand and strengthen their market position. These companies are implementing next-generation bone densitometer technologies into their products, such as radiography, computed tomography, fluoroscopy, mammography, diffraction, 3D visualization, modelling, and others. For instance, in February 2024, FUJIFILM India Pvt. Ltd., an India-based subsidiary of FUJIFILM Holdings Corporation, introduced its advanced Dual-Energy X-ray Absorptiometry (DEXA) system, FDX Visionary-DR, at the newly inaugurated Center for Sports Injury in Delhi. Launched on February 11, the installation enhances the facility’s diagnostic capabilities with faster, high-quality bone-density assessments for orthopedic and sports-medicine needs. The initiative strengthens FUJIFILM India’s commitment to expanding access to cutting-edge bone densitometry technology across the country.

What Are Latest Mergers And Acquisitions In The Bone Densitometer Market?

In October 2025, Blackstone and TPG, US-based private equity firms, acquired Hologic Inc. for $18.3 billion. Through this acquisition, the firms aim to leverage Hologic’s diagnostic imaging portfolio, including its bone densitometry systems, to expand their presence in the medical technology sector. Hologic Inc. is a US-based medical technology company that provides diagnostic imaging solutions, including DXA bone densitometers for measuring bone mineral density.

Regional Outlook

North America was the largest region in the bone densitometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Bone Densitometer Market?

The bone densitometer market consists of sales of central DEXA and peripheral DEXA. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.